Isothiocyanates inhibited gluconeogenesis and hepatic glucose-6-phosphatase (G6P) expression in hepatoma cells and improved glucose tolerance and insulin signaling sensitivity (Waterman et al., 2016). Here, G6PC1 is linked to hepatocellular carcinoma.